ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate - Oncology Material Licensing at Eli Lilly and Company - ApplyBlast

Associate - Oncology Material Licensing

Eli Lilly and Company

4 months ago

4.0 on Glassdoor

United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate, Oncology Material Licensing at Eli Lilly manages the full lifecycle of material licensing and transfer agreements for early-phase oncology research. This role involves negotiating contracts for biological materials, ensuring compliance with regulations, and supporting scientists in accessing critical research tools like cell lines and animal models.

Responsibilities

Negotiate and execute material license and transfer agreements
Assess incoming material procurement and in-license requests
Maintain accurate records of licensed materials and use restrictions
Collaborate with legal, scientific, and project management teams
Evaluate material transfer requests against compliance regulations

Skills

Qualifications

Bachelor's degree in Biology or Biochemistry3+ years in contract managementExperience in biotechnology or pharmaceutical setting

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.